Breakfast by the Bay for World Mental Health Day 2025
Event Details: Date: Friday, 10 October 2025 Time: 7:00am – 9:00am Location: The University Club of Western Australia – Banquet...
Continue reading
News & events
Discover our latest videos on the Perron Institute YouTube channel. See the Perron Institute’s appearances in the media here.
Team Andy’s Swim for Telethon 2025
Event Details: Date: Sunday, 19 October 2025 Time: 6:00am – 3:00pm Location: Rottnest Island to Elizabeth Quay TEAM ANDY’S EPIC SWIM...
Continue reading
Perron Institute Hole in One Day
Event Details: Date: Sunday, 12 October 2025 Time: 2:00pm – 3:30pm Location: Wembley Golf Course Perron Institute Hole in One...
Continue reading
Perron Mini Golf and Putting Challenge – Supporting Telethon
Mini Golf with Fat Cat Date: 7 & 9 October 2025 Location: Wembley Golf Course Time: 9:00 am – 5:00pm...
Continue reading
Major research grant for youth mental health research on personalised therapies
Statistics show that young Australians under 25 are at a high risk of mental health disorders, with around one in...
Continue reading
Measuring heel bone mineral density to predict increased dementia risk
Further evidence of a link between low bone mineral density and dementia is provided in a recently published collaborative study...
Continue reading
WA Government support for novel treatments for youth mental health
Depression, the most common mental illness worldwide, is a significant and growing public health issue causing a high economic burden...
Continue reading
Perron Institute pays tribute to its retiring Medical Director
Distinguished neurologist, Clinical Professor David Blacker AM, recognised nationally for his clinical and research achievements, has retired as Medical Director...
Continue reading
Perron Institute appoints new Medical Director
Western Australia’s Perron Institute has announced the appointment of Professor Merrilee Needham to the leadership role of Medical Director. Professor...
Continue reading
Researchers discover novel pathway of how cells respond to exercise and physical activity
Scientists at the Perron Institute for Neurological and Translational Science and The University of Western Australia have made a significant...
Continue reading
Final patient dosed in Phase 2 stroke trial
Dosing of patients in Argenica Therapeutics’ Phase 2 clinical trial of the neuroprotective drug ARG-007 in acute ischaemic stroke has...
Continue reading
WA research brings hope for tackling rare neurological disorders in children
A severe genetic disorder known as Angelman syndrome (AS) is one of three rare conditions targeted in WA research receiving...
Continue reading